Antiphospholipid Antibodies in Multiple Sclerosis
Author Information
Author(s): Bidot Carlos J, Horstman Lawrence L, Jy Wenche, Jimenez Joaquin J, Bidot Carlos Jr, Ahn Yeon S, Alexander J Steven, Gonzalez-Toledo Eduardo, Kelley Roger E, Minagar Alireza
Primary Institution: University of Miami Dept. of Medicine, Miller School Of Medicine
Hypothesis
Is there a relationship between antiphospholipid antibodies and clinical features in multiple sclerosis patients?
Conclusion
Increased antiphospholipid antibodies are associated with exacerbations of multiple sclerosis.
Supporting Evidence
- 80% of MS subjects in exacerbation had elevated IgM antibodies.
- Less than half of MS patients in remission had elevated IgM antibodies.
- None of the MS patients had elevated IgG against any of the target antigens.
Takeaway
This study found that people with multiple sclerosis have more antibodies when their symptoms get worse, but we don't know why yet.
Methodology
The study involved 24 subjects with relapsing-remitting MS who underwent MRI and blood tests for antiphospholipid antibodies.
Limitations
The study is preliminary and involves a small sample size.
Participant Demographics
20 females and 4 males with a mean duration of neurological symptoms prior to diagnosis of 5.3 months.
Statistical Information
P-Value
p = 0.0002
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website